ClearPoint Neuro (CLPT) Current Deferred Tax Assets (2012)

Name: ClearPoint Neuro (CLPT) Current Deferred Tax Assets (2012) | Business Quant
Creator: Business Quant

ClearPoint Neuro recorded quarterly Current Deferred Tax Assets of $47639.0 in Q4 2012.

ClearPoint Neuro's Current Deferred Tax Assets history runs 1 years deep, the most recent figure standing at $47639.0 for Q4 2012.

In Q4 2012, Current Deferred Tax Assets changed N/A year-over-year to $47639.0; the TTM figure through Dec 2012 stood at $47639.0 (changed N/A YoY), while the FY2012 annual figure was $47639.0, changed N/A from the prior year.
Current Deferred Tax Assets came in at $47639.0 for Q4 2012 at ClearPoint Neuro.
In the past five years, Current Deferred Tax Assets ranged from a high of $47639.0 in Q4 2012 to a low of $47639.0 in Q4 2012.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn
10	ClearPoint Neuro	375.84 Mn	340.24 Mn	7.76 Mn

Download Data 🔒

Date	Value
Dec 31, 2012	47,639.00
Dec 31, 2012	47,639.00